The drugmaker said one patient became ill after being treated with its experimental weight-loss drug, danuglipron.

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...

The nonprofit Physicians Committee for Responsible Medicine, which promotes the use of human-relevant test methods to replace ...

The move comes after lawmakers sought to force the agency to update regulations that would allow alternatives to animal ...

| Discover how AI and RWD are transforming drug development by optimizing clinical trial protocols, enhancing recruitment, ...

In a Q&A with Jeff Casberg, MS, RPh, senior vice president of clinical pharmacy services at IPD Analytics, Casberg explains ...

Goldman Sachs estimates that AI drug discovery and breakthroughs like gene editing will add 0.5% to 2.5% to the U.S. gross ...

Northeastern University researchers resurrected an extinct plant gene, turning back the evolutionary clock to pave a path forward for the development and discovery of new drugs.

Researchers in pharma and beyond have historically glommed onto a limited number of disease targets, limiting innovation. AI ...

Trump recently proposed tariffs on pharmaceutical products. Experts say this could lead to added costs, drug shortages and ...

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive ...

The US Food and Drug Administration announced Thursday that it will be phasing out a requirement that monoclonal antibodies ...